Dashyant Dhanak

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Dashyant Dhanak:

Form 4 holding EVP & Chief Scientific Officer

INCYTE CORP

Security class
Common Stock
Shares / value
58,968
Estimated value
$3,626,532
Report date
14 Jul 2023
Price
$61.50
Ownership
Direct
Form 4 holding EVP & Chief Scientific Officer

Deciphera Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
$0
Report date
11 Jun 2024
Price
$10.58
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP & Chief Scientific Officer

INCYTE CORP

Security class
Employee Stock Option (right to buy)
Shares / value
16,896
Estimated value
Report date
14 Jul 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Dashyant Dhanak

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .